Christopher J. Matthews

Discovery of Potent, Isoform-Selective Inhibitors of Histone Deacetylase Containing Chiral Heterocyclic Capping Groups and a<i>N</i>-(2-Aminophenyl)benzamide Binding Unit

Charles M. Marson, Christopher J. Matthews, Elena Yiannaki et al. · Journal of Medicinal Chemistry · 2013 · 55 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a <i>N</i>-(2-Aminophenyl)-benzamide Binding Unit

Charles M. Marson, Christopher J. Matthews, Stephen J. Atkinson et al. · Journal of Medicinal Chemistry · 2015 · 54 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

Outcomes of Primary Reverse Total Shoulder Arthroplasty in Patients Younger Than 65 Years Old

Christopher J. Matthews, Thomas W. Wright, Kevin W. Farmer et al. · The Journal Of Hand Surgery · 2019 · 33 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +10

Novel Chiral Skeletons for Drug Discovery: Antibacterial Tetramic Acids

Chloe A. Holloway, Christopher J. Matthews, Yong‐Chul Jeong et al. · Chemical Biology & Drug Design · 2011 · 28 citations

Pharmacy, Chemistry, Medicinal Chemistry +14

Discovery of a structurally novel, drug-like and potent inhibitor of peptidylarginine deiminase

Patrizia Ferretti, Kin Pong U, Barbora Vagaská et al. · MedChemComm · 2013 · 11 citations

Pharmacy, Medicinal Chemistry, Pharmacology +10